Document is current
Any future updates will be listed below
-
Authors
Aragam, Krishna G. https://orcid.org/0000-0003-3223-9131
Jiang, Tao
Goel, Anuj https://orcid.org/0000-0003-2307-4021
Kanoni, Stavroula https://orcid.org/0000-0002-1691-9615
Wolford, Brooke N. https://orcid.org/0000-0003-3153-1552
Atri, Deepak S. https://orcid.org/0000-0001-8139-5419
Weeks, Elle M. https://orcid.org/0000-0002-4317-4444
Wang, Minxian https://orcid.org/0000-0002-3753-508X
Hindy, George
Zhou, Wei https://orcid.org/0000-0001-7719-0859
Grace, Christopher
Roselli, Carolina https://orcid.org/0000-0001-5267-6756
Marston, Nicholas A.
Kamanu, Frederick K. https://orcid.org/0000-0001-7208-1047
Surakka, Ida
Venegas, Loreto Muñoz
Sherliker, Paul
Koyama, Satoshi https://orcid.org/0000-0002-9286-0360
Ishigaki, Kazuyoshi https://orcid.org/0000-0003-2881-0657
Åsvold, Bjørn O. https://orcid.org/0000-0003-3837-2101
Brown, Michael R.
Brumpton, Ben https://orcid.org/0000-0002-3058-1059
de Vries, Paul S.
Giannakopoulou, Olga
Giardoglou, Panagiota
Gudbjartsson, Daniel F. https://orcid.org/0000-0002-5222-9857
Güldener, Ulrich https://orcid.org/0000-0001-5052-8610
Haider, Syed M. Ijlal
Helgadottir, Anna https://orcid.org/0000-0002-1806-2467
Ibrahim, Maysson
Kastrati, Adnan
Kessler, Thorsten https://orcid.org/0000-0003-3326-1621
Kyriakou, Theodosios
Konopka, Tomasz
Li, Ling https://orcid.org/0000-0002-3280-9475
Ma, Lijiang
Meitinger, Thomas
Mucha, Sören https://orcid.org/0000-0002-1647-2526
Munz, Matthias https://orcid.org/0000-0002-4728-3357
Murgia, Federico https://orcid.org/0000-0002-3608-845X
Nielsen, Jonas B.
Nöthen, Markus M.
Pang, Shichao https://orcid.org/0000-0002-4111-2864
Reinberger, Tobias
Schnitzler, Gavin
Smedley, Damian https://orcid.org/0000-0002-5836-9850
Thorleifsson, Gudmar https://orcid.org/0000-0003-4623-9087
von Scheidt, Moritz https://orcid.org/0000-0001-7159-8271
Ulirsch, Jacob C. https://orcid.org/0000-0002-7947-0827
,
,
Danesh, John
Arnar, David O.
Burtt, Noël P.
Costanzo, Maria C. https://orcid.org/0000-0001-9043-693X
Flannick, Jason https://orcid.org/0000-0002-3618-795X
Ito, Kaoru https://orcid.org/0000-0003-1843-773X
Jang, Dong-Keun
Kamatani, Yoichiro
Khera, Amit V. https://orcid.org/0000-0001-6535-5839
Komuro, Issei https://orcid.org/0000-0002-0714-7182
Kullo, Iftikhar J. https://orcid.org/0000-0002-6524-3471
Lotta, Luca A.
Nelson, Christopher P.
Roberts, Robert https://orcid.org/0000-0002-6792-4633
Thorgeirsson, Gudmundur
Thorsteinsdottir, Unnur
Webb, Thomas R. https://orcid.org/0000-0001-5998-8226
Baras, Aris https://orcid.org/0000-0002-6830-3396
Björkegren, Johan L. M. https://orcid.org/0000-0003-1945-7425
Boerwinkle, Eric
Dedoussis, George
Holm, Hilma https://orcid.org/0000-0002-9517-6636
Hveem, Kristian
Melander, Olle
Morrison, Alanna C. https://orcid.org/0000-0001-6381-4296
Orho-Melander, Marju https://orcid.org/0000-0002-3578-2503
Rallidis, Loukianos S.
Ruusalepp, Arno
Sabatine, Marc S.
Stefansson, Kari https://orcid.org/0000-0003-1676-864X
Zalloua, Pierre
Ellinor, Patrick T.
Farrall, Martin https://orcid.org/0000-0003-4564-2165
Danesh, John
Ruff, Christian T.
Finucane, Hilary K. https://orcid.org/0000-0003-3864-9828
Hopewell, Jemma C.
Clarke, Robert https://orcid.org/0000-0002-9802-8241
Gupta, Rajat M.
Erdmann, Jeanette https://orcid.org/0000-0002-4486-6231
Samani, Nilesh J. https://orcid.org/0000-0002-3286-8133
Schunkert, Heribert https://orcid.org/0000-0001-6428-3001
Watkins, Hugh https://orcid.org/0000-0002-5287-9016
Willer, Cristen J. https://orcid.org/0000-0001-5645-4966
Deloukas, Panos
Kathiresan, Sekar https://orcid.org/0000-0002-3711-7101
Butterworth, Adam S. https://orcid.org/0000-0002-6915-9015
,
de Vries, Paul S.
von Scheidt, Moritz
- License Information
-
More Information
Article History
Received: 26 April 2021
Accepted: 17 October 2022
First Online: 6 December 2022
Competing interests
: All deCODE affiliated authors are employees of deCODE/Amgen. The TIMI Study Group has received institutional research grant support through Brigham and Women’s from Abbott, Amgen, Aralez, AstraZeneca, Bayer HealthCare Pharmaceuticals, BRAHMS, Daiichi-Sankyo, Eisai, GlaxoSmithKline, Intarcia, Janssen, MedImmune, Merck, Novartis, Pfizer, Poxel, Quark Pharmaceuticals, Roche, Takeda, The Medicines Company, and Zora Biosciences. R.C., J.C.H., M.I. and F.M. work at the Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, which receives research grants from industry that are governed by the University of Oxford contracts that protect its independence and has a staff policy of not taking personal payments from industry; further details can be found at . A.S.B. reports grants outside of this work from AstraZeneca, Bayer, Biogen, BioMarin, Bioverativ, Merck, Novartis and Sanofi. A.B. and L.A.L. are employees of Regeneron Pharmaceuticals and the spouse of C.J.W. works at Regeneron Pharmaceuticals. J.L.M.B. and A.R. are members of the board of directors, founders and shareholders of Clinical Gene Networks AB that has an invested interest in STARNET. J.D. serves on scientific advisory boards for AstraZeneca, Novartis, and UK Biobank and has received multiple grants from academic, charitable and industry sources outside of the submitted work. J.C.U. has received compensation for consulting from Goldfinch Bio and is an employee of Patch Biosciences. O.G. became a full-time employee of UCB while this manuscript was being drafted. The other authors declare no conflicts of interest.
